Trials / Conditions / Autoimmune Diabetes

Autoimmune Diabetes

22 registered clinical trials studyying Autoimmune Diabetes — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intensive Dietary and Activity Counselling (IDAC) NCT06670625	Lund University	N/A
Completed	Metabolic and Immunoinflammatory Profiles in Adults With Newly Diagnosed Diabetes NCT07522502	West Kazakhstan Marat Ospanov Medical University	—
Recruiting	Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years NCT05866536	Massachusetts General Hospital	Phase 2
Not Yet Recruiting	Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA NCT04698330	Second Xiangya Hospital of Central South University	Phase 4
Completed	Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via NCT05168657	University of Colorado, Denver	N/A
Recruiting	Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes NCT05180591	Massachusetts General Hospital	Phase 2
Recruiting	Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study) NCT05319990	University of Colorado, Denver	—
Recruiting	Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflamma NCT04902807	Institut National de la Santé Et de la Recherche Médicale, France	—
Completed	Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting NCT04793165	Hospital Italiano de Buenos Aires	N/A
Unknown	Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D NCT04335513	University of Colorado, Denver	N/A
Completed	Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance NCT04074668	University of Colorado, Denver	—
Active Not Recruiting	MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus NCT03945747	University of Colorado, Denver	—
Completed	Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function NCT03618420	University of Colorado, Denver	Phase 1 / Phase 2
Completed	Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes NCT03345004	Diamyd Medical AB	Phase 2
Unknown	Metformin Plus Insulin on Non-obese Autoimmune Diabetes NCT03513874	Second Xiangya Hospital of Central South University	Phase 4
Unknown	Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes NCT03011021	Second Xiangya Hospital of Central South University	Phase 1 / Phase 2
Unknown	Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus NCT03011008	Second Xiangya Hospital of Central South University	Phase 4
Active Not Recruiting	Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes NCT02081326	Massachusetts General Hospital	Phase 2
Unknown	Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus NCT01559025	Federal University of São Paulo	Phase 3
Completed	Medtronic Minimed Overnight Closed-Loop System NCT01881009	Bruce A. Buckingham	N/A
Withdrawn	Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA) NCT01148238	Norwegian University of Science and Technology	—
Terminated	Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes NCT00837759	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 2